2011

Prevalence, clinical features and outcomes of neonatal Covid-19 infection at a tertiary center in Turkey

Aim: Newborns constitute a special and sensitive group within the pediatric age group due to their unique characteristics and disease. We evaluated the prevalence, clinical features and outcomes of neonates admitted to emergency department and hospitalized with suspected SARS-CoV-2 infection. Materials and Methods: In this retrospective, single centre study all neonates admitted to emergency department with suspected SARS-CoV-2 infection between March 11, 2020 and March 11, 2021 were enrolled. Results: Fifty-five newborns were hospitalized in (Neonatal Intensive Care Unit) NICU with a suspicion of SARS-CoV-2 infection during the study period. PCR was positive in 14 newborns out of 55 hospitalized newborns (25.5%). Thirteen (92.8%) newborns with a positive SARS-CoV-2 PCR had household contact. The most common findings on admission were fever (43%), feeding intolerance (29%) and tachypnea (14%). One (7%) newborn was asymptomatic on admission. Three newborns (21%) had lymphopenia. Seven (50%) newborns had leukopenia, but none of them had neutropenia. D-dimer levels of nine (64%) SARS-CoV-2 positive newborns were elevated but none of these patients had coagulation disorders or problems needing treatment. Five of fourteen PCR positive newborns (35%) needed suplemental oxgen, while a newborn baby (7%) neeeded non-invasive mechanical ventilation. Conclusions: Fever is a common symptom in SARS-CoV-2 infected newborns but new symptoms will be encountered in the course of the pandemics. Clinical information and course of SARS-CoV-2 in newborns has an obscurity. In the pandemic conditions all newborns, especially having a contact with a SARS-CoV-2 infected person must be tested for SARS-CoV-2 even if having no symptoms.

PDF

___

1. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. NEJM 2020;382:727-33.
2. Morand A, Fabre A, Minodier P, et al. COVID-19 virus and children: what do we know? Arch Pediatr 2020;27:117-8.
3. Williams K, Thomson D, Seto I, et al. StaR Child Health Group. Standart 6: Age groups for pediatric trials. Pediatrics 2012;129:153-60.
4. Kanburoglu MK, Tayman C, Oncel MY, et al. A Multicentered Study on Epidemiologic and Clinical Characteristics of 37 Neonates With Community-acquired COVID-19. Pediatr Infect Dis J 2020;39:e297-e302.
5. dos Santos Beozzo GPN, de Carvalho WB, Krebs VLJ, et al. Neonatal manifestations in COVID-19 patients at a Brazilian tertiary center. Clinics 2020;75:e2407.
6. Nanavati R, Mascarenhas D, Goyal M, et al. A single- center observational study on clinical features and outcomes of 21 SARS-CoV-2-infected neonates from India. Eur J Pediatr 2021;180:1895-906.
7. Ng KF, Bandi S, Bird PW, et al. COVID-19 in Neonates and Infants:Progression and Recovery. Pediatr Infect Dis J 2020;39:e140-e2.
8. Turkish Ministry of Health. COVID-19 Yeni Koronavirus Hastaligi [Online]. 2020. Available at: https:// covid19bilgi.saglik.gov.tr/tr. Accessed June 23, 2020.
9. Erdeve O, Cetinkaya M, Bas AY, et al. The Turkish Neonatal Society proposal for the management of COVID-19 in the neonatal intensive care unit. Turkish Archives of Pediatrics 2020;55:86-92.
10. Colomer BF, Manuel Sánchez-Luna M, de Alba Romero C, et al. Neonatal Infection Due to SARS-CoV-2: An Epidemiological Study in Spain. Front Pediatr 2020;8:580-4.
11. Karabay M, Cinar N, Suzan OK, et al. Clinical characteristics of confirmed COVID-19 in newborns: a systematic review. J Matern Fetal Neonatal Med 2020;1-12.
12. Dong Y, Mo X, Hu Y, et al. Epidemiology of COVID-19 among children in China. Pediatrics 2020;145:e20200702.
13. Bai K, Liu W, Liu C, et al. Clinical analysis of 25 COVID-19 infections in children. Pediatric Infectious Disease Journal 2020;39:e100-e3.
14. Whittaker E, Bamford A, Kenny J, et al. for the PIMS-TS Study Group and EUCLIDS and PERFORM Consortia Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2. JAMA 2020;324:259- 69.
15. Zheng Z, Peng F, Xu B, et al. Risk factors of critical & mortal COVID19 cases: A systematic literature review and meta-analysis. J Infect 2020;81:e16-e25.
16. Zhang L, Yan X, Fan Q, et al. D-dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost 2020;18:1324-9.
17. Panahi L, Amiri M, Pouy S. Clinical Characteristics of COVID-19 Infection in Newborns and Pediatrics: A Systematic Review. Arch Acad Emerg Med 2020;18;8:e50.
18. Xia W, Shao J, Guo Y, et al. Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults. Pediatric Pulmonology 2020;55:1169-74.
19. Yen CY, Hung MC, Wong YC, et al., Role of intravenous immunoglobulin therapy in the survival rate of pediatric patients with acute myocarditis: A systematic review and meta-analysis. Sci Rep 2019;18;9:10459.
20. Son MBF, Friedman K. Covid-19: Multisystem Inflammatory Syndrome in Children (Mis-C) Clinical Features, Evaluation, and Diagnosis. UpToDate 2021. Available online: https://www. uptodate.com/contents/covid19-multisystem- inflammatorysyndrome-in-children-mis-c-clinicalfeatures-evaluation-and-diagnosis (accessed on 15 May 2021)
21. Caforio AL. COVID-19: Cardiac manifestations in adults. In: Mancini D & Dardas TF. UpToDate 2021. Available online: https://www.uptodate.com/ contents/covid-19-cardiac-manifestationsin- adults.
22. Deville JG, Song E, Ouellette CP. COVID-19: Management in children. In: Mancini D & Dardas TF. UpToDate 2021.Available online: https://www. uptodate.com/contents/covid-19-management-in- children